The First Line of Defense Against Cardiac Hypertrophy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|13|4|670-680

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.13, Iss.4, 2013-05, pp. : 670-680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 9, Iss. 2, 2009-06 ,pp. : 141-148

Bentham Science Publishers

Access to resources Recommend Favorite

Pleiotropic Effect of Statins as Antioxidants on Cardiac Hypertrophy

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 8, Iss. 2, 2008-06 ,pp. : 167-171

Bentham Science Publishers

Access to resources Recommend Favorite

Meloxicam Prevents Load-Induced Cardiac Hypertrophy in Mice

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 143-146

Bentham Science Publishers

Access to resources Recommend Favorite

Host defense against bacterial keratitis

By O'Callaghan Richard J.   Girgis Dalia O.   Dajcs Joseph J.   Sloop Gregory D.  

Ocular Immunology and Inflammation, Vol. 11, Iss. 3, 2003-09 ,pp. : 171-181

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA Regulation and Role in Stem Cell Maintenance, Cardiac Differentiation and Hypertrophy

By  

Current Molecular Medicine, Vol. 13, Iss. 5, 2013-01 ,pp. : 757-764

Bentham Science Publishers

Access to resources Recommend Favorite